l General Information |
Product Name | LY2584702 |
General description | LY2584702 is a selective, ATP-competitive p70S6K inhibitor. |
Synonym | 4-[4-[4-[4-fluoro-3-(trifluoromethyl)phenyl]-1-methylimidazol-2-yl]piperidin-1-yl]-1H-pyrazolo[3,4-d]pyrimidine |
Purity | ≥98.0%(HPLC) | CAS Number | 1082949-67-4 |
Formula | C21H19F4N7 | Molecular Weight | 445.42 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | solid |
Solubility(25℃) | DMSO | ~1mg/mL(warmed） |
Ethanol | Insoluble |
Water | Insoluble |
l Biological Information |
Biochem/Physiol
Actions | LY2584702 is a selective, ATP-competitive p70S6K inhibitor with IC50 of 4 nM. |
Application | LY2584702 has been used in trials studying the treatment of Cancer, Advanced Cancer, Renal Cell Carcinoma, Metastases, Neoplasm, and Neuroendocrine Tumors, among others. |
l Storage |
Storage temp. | -20℃ |
l Precautions and Disclaimer |
This
product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |
